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Abstract: The colonic epithelium is coated by
a visco-elastic gel, mucus that lubricates and
protects the mucosa from the external
environment. Mucus glycoproteins (mucins,
MUCs)
are
major
macromolecular
components with MUC2 representing the
major gel-forming secretory mucin.
Previously we purified MUC2 from a cell
culture environment with either three rounds
of isopicnic centrifugation or gel filtration
chromatography followed by a single round of
centrifugation. In the present work, using
rate-zonal centrifugation in a gradient of
guanidinium chloride we fractionated this
purified MUC2 and its subunits. Analyses of
the fractions showed that the unreduced
MUC2 molecules are quite large and
polydisperse in molecular mass. Reduction of
disulphide bonds cleaved the large
polydisperse molecules into smaller and more
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Introduction
Human colonic mucosa synthesises and secretes
mucins which constituent a highly-hydrated, visco-elastic
gel barrier (mucus) on the luminal side of the intestine.
Once secreted, mucins form this barrier, not only to
protect the delicate epithelial cells against the
extracellular environment, but also to select substances
for binding and uptake by these epithelia (1,2).
Considerable advances have been made in recent years in
the understanding of the biochemical and biophysical
characteristics of mucins. Their hydrodynamic properties
are consistent with the macromolecules being linear
flexible chains that occupy an expanded spheroidal
domain in dilute solution (3). The specific gel forming
ability of mucins is due to a combination of structural
features of the mucin molecules, which have an
oligomeric structure containing several monomeric
glycoproteins (4).
In the human colon the major secretory mucin MUC2
consists of two heavily glycosylated domains: the variable
number of tandem repeat (VNTR) domain and the non-

uniformly sedimenting species. Individual
fractions from both the unreduced and
reduced MUC2 molecules were then subjected
to laser light-scattering performed as absolute
intensity measurements to obtain average
molecular mass (Mr) and radius of gyration
(RG). The Mr for the unreduced and reduced
6
6
MUC2 was 30 x 10 and 16 x 10 and RG was
in the range 290-309 nm and 200-260 nm,
respectively. We concluded that colonic MUC2
mucin can be described as polydisperse and
the combination of rate-zonal centrifugation
and laser light-scattering techniques could
certainly be applied as an effective method to
determine their polydispersity.

Key Words: Polydispersity, colonic mucins,
rate-zonal centrifugation, light-scattering

tandemly repeated domain. The MUC2 gene has been
mapped to chromosome 11p15 (5). Recent studies of
MUC2 from cell culture suggest that the MUC2
apoprotein is N-glycosylated in the endoplasmic reticulum
(ER) prior to disulphide bond formation, followed by Oglycosylation in the Golgi (4,6-9). It is also clear that
MUC2 undergoes further oligomerisation within the cell
to produce very high Mr mucins (9).
Using two different approaches we previously purified
colonic MUC2 mucin from a cell culture environment
(10). In the present study we attempted to investigate
molecular mass differences of the unreduced and reduced
MUC2 mucins obtained from the same cell line (PC/AA)
with rate-zonal centrifugation in a gradient of
guanidinium chloride. We have demonstrated the
presence of a huge difference in their sedimenting rates.
The individual fractions of both populations were then
analysed with laser light-scattering performed as
absolute-intensity measurements. The results of these
two experiments suggested that colonic MUC2 mucins
were quite large and polydisperse in molecular mass and
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the combination of rate-zonal centrifugation and laser
light-scattering techniques could be used as a suitable
approach to demonstrate their polydispersity.

Materials and Methods
Chemicals
PBS tablets, EDTA, goat anti-rabbit IgG horseradish
peroxidase conjugate, nitroblue tetrazolium, 5-bromo-4chloro-3-indolyl phosphate, periodic acid, Schiff's
reagent, dithiothreitol (DTT), iodoacetamide and
guanidinium chloride (practical grade) were purchased
from Sigma Chemical Co. (Poole, UK). Stock solutions of
guanidinium chloride (approx. 8 M) were treated with
charcoal before use.
Cell culture and collection of mucins
The PC/AA adenoma cell line was derived from a
single, large, colonic tubular adenoma of 3-4 cm diameter
that exhibited only mild dysplasia. The cells were
continuously passaged in vitro at 37 °C in 5% CO2 in air
and 3T3 feeder cells on collagen type IV-coated T25
flasks. The cell layers were solubilised with 6 M GuHCl
containing proteinase inhibitors.
Antibodies
A polyclonal antiserum, LUM2-3, was a kind gift from
Dr. I. Carlstedt (University of Lund, Sweden). This
antiserum was raised against a synthetic peptide
NGLQPVRVEDPDGC in the non-TR of the molecule
towards the C-terminus (11).
Preparation of reduced mucin subunits
Reduced mucin subunits were obtained following
dialysis of the purified whole mucins into GuHCl reduction
buffer (6 M guanidinium chloride/0.1 M Tris/5 mM
EDTA, pH 8.0) by treatment with 10 mM dithiothreitol
for 5 h at 37 °C. Iodoacetamide was then added to a final
concentration of 25 mM and the mixture left in the dark
overnight at room temperature. Reduced mucin subunits
were dialysed into 6 M guanidinium chloride and stored
at 4 °C.
Alternatively the mucins may be reduced on the
membrane after slot blotting using DTT and then
iodoacetamide in reduction buffer. In brief, the blotted
membrane was washed in distilled water for a few
minutes and incubated in 6 M GuHCl reduction buffer
containing 10 mM DTT at room temperature for 15 min.
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After pouring DTT off, the membrane was incubated in 6
M GuHCl reduction buffer containing 25 mM
iodoacetamide at room temperature for 10 min and
washed twice with distilled water (5 min each wash) and
blocked in TBST buffer containing 1% (w/v) skimmed
milk powder for immunoblotting assay.
Rate-zonal centrifugation
Rate zonal centrifugation was carried out as
previously described by Sheehan and Carlstedt (12). The
purified intact MUC2 mucin and its reduced subunits were
dialysed into 4 M GuHCl. The samples in 4 M GuHCl were
layered onto the top of the preformed GuHCl gradients
(6-8 M), produced by using a linear gradient maker
(MSC), with a Hamilton syringe and centrifuged in a
Beckman SW40 (13 ml gradient tube containing 500 µl
of sample, at 40,000 rpm, at 20 °C) swing out rotor for
2.5 h. The tubes were unloaded from the top into
twenty-four 500 µl fractions. Fractions were analysed by
the LUM2-3 antibody and PAS (Periodic Acid Schiff's).
The molarity of GuHCl was determined by measuring the
refractive index with an Abbe refrectometer.
Laser light-scattering
The fractions obtained from rate-zonal centrifugation
performed on the purified intact and reduced MUC2
mucin molecules were passed through an in-line Dawn®
DSP laser photometer and a Wyatt/Optilab 903
interferometric refractometer (Optichem, Clywd, UK) to
measure light scattering and sample concentration
respectively. Light scattering measurements were taken
continuously at 18 angles between 15° and 151°.
Determination of molecular mass and radius of
gyration
Unreduced and reduced mucin subunits in 4 M GuHCl
were chromatographed on a Sephacryl S300 column (10
x 2 cm) eluted with 4 M GuHCl at a flow rate of 0.5
ml/min and the fractions passed through an on-line Dawn
DSP laser photometer and a Wyatt/Optilab 903
interferometric refractometer (Optichem, Clywd, UK) to
measure light scattering and sample concentration
respectively. Light-scattering measurements were taken
continuously at 18 angles between 15° and 151° and the
data analysed using the following equation:

Rθ = MrP(θ) - 2A 2cM2r P 2(θ)
KC
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Figure 1.

where µ = (4π / λ) sin(θ/2), r2 is the mean square radius
of a molecule with respect to its centre of gravity. The
square root of the mean square radius is also called the
RG (radius of gyration).

The Mr and RG of the intact and reduced MUC2 mucins
in fractions across the LUM2-3 distribution were
determined by in-line laser light scattering after ratezonal centrifugation and the values are summarised in
Tables 1 and 2. The Mr distribution of the MUC2
molecules was detected using a Sephacryl S300 column
(10 x 2 cm) eluted with 4 M GuHCl at a flow rate of 0.5
ml/min. The effluent was monitored by a multi-angle light
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The molecular mass distribution of MUC2
macromolecules was determined by rate-zonal
centrifugation using gradients of guanidinium chloride as
described by Sheehan and Carlstedt (3). The distribution
of intact MUC2 mucins, as monitored by using PAS and
anti-MUC2 antibody LUM2-3 measurements, show at
least three peaks of increasing height from the top of the
gradient (Fig. 1). The PAS profile of the intact mucins
was quite similar to the antibody profile (Fig. 1). The
polydispersity of the MUC2 mucins obtained from the
same cell line obscured when they were reduced to the
subunits (Fig. 2). The distribution of the reduced MUC2
subunits showed a more uniform profile with the
antibody and PAS.

5

Rate-zonal GuHCl gradient centrifugation of the intact
MUC2 mucins
The intact MUC2 mucins were dialysed against 4 M GuHCl
and 500 µl of the samples were layered onto preformed
GuHCl gradients (6-8 M) and thereafter subjected to
centrifugation in a Beckman SW 40 swing-out rotor at
40,000 rpm for 2.5 h at 20 °C. After centrifugation the
tubes were emptied from the top and the fractions (0.5 ml)
were analysed with anti-MUC2 antibody LUM2-3 ( ■ ) and
PAS ( ◆ ). Refractive index was measured to determine the
molarity of GuHCl ( –.–.–.–.).
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where Rθ is the excess Rayleigh ratio, C is the
concentration of the solute molecules in the solvent, Mr is
the average molecular mass, A2 is the second virial
coefficient, K* is an optical constant = 4π2n02 (dn/dc)2 λ0-4
NA-1, where n0 is the refractive index of the solvent at the
incident radiation (vacuum) wavelength, λ0 is the incident
radiation (vacuum) wavelength, expressed in nanometers,
NA is Avogadro’s number, equal to 6.022 X 1023, and
dn/dc is the differential refractive index increment of the
solvent-solute solution with respect to a change in solute
concentration (this factor must be measured
independently using an refractive index detector), P(θ) is
a theoretically-derived form factor. It can be related to
the distance between scattering centres in the molecule
by
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Figure 2.
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Rate-zonal GuHCl gradient centrifugation of the reduced
MUC2 subunits
The MUC2 subunits were dialysed against 4 M GuHCl and
500 µl of the samples were layered onto preformed GuHCl
gradients (6-8 M) and thereafter subjected to centrifugation
in a Beckman SW 40 swing-out rotor at 40,000 rpm for
2.5 h at 20 °C. After centrifugation the tubes were emptied
from the top and the fractions (0.5 ml) were analysed with
anti-MUC2 antibody LUM2-3 (
) and PAS (
).
Refractive index was measured to determine the molarity of
GuHCl ( –.–.–.).

scattering detector (Dawn® DSP system) and the
molecular weight distribution of intact MUC2 molecules
(Fig. 3) and the reduced subunits (Fig. 4) were
determined. The data show that the reduced MUC2 mucin
subunits are of similar molecular mass (Mm) and size
(RG). However, there was a slight increase in the size (RG)
of the polydisperse intact MUC2 species.
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Table 1.

Molecular mass and radius of gyration data of the intact
MUC2 mucins
The fractions across the LUM2-3 distribution of the intact
MUC2 mucins on the rate-zonal guanidinium gradient were
chromatographed at room temperature on a Sephacryl
S300 column (10 x 2 cm) eluted with 4 M GuHCl at a flow
rate of 0.5 ml/min. The effluent was monitored by a multiangle light scattering detector (Dawn® DSP system) and a
Wyatt/Optilab interferometric refractometer.

Fraction
number

Molecular mass
7
(Da X 10 )

Radius of
gyration (nm)

5
8
12
18
20

2.7
2.9
3.2
3.8
4.1

292
294
295
304
307

Table 2.

Fraction
number

Molecular mass
7
(Da X 10 )

Radius of
gyration (nm)

4
6
8

1.5
1.6
1.6

202
203
206

25.0x10 6
Molecular weight (Daltons)

Molecular weight (Daltons)

9.0x10 7

Molecular mass and radius of gyration data of the MUC2
subunits
The fractions across the LUM2-3 distribution of reduced
MUC2 subunits on the rate-zonal guanidinium gradient
were chromatographed at room temperature on a
Sephacryl S300 column (10 x 2 cm) eluted with 4 M
GuHCl at a flow rate of 0.5 ml/min. The effluent was
monitored by a multi-angle light scattering detector (Dawn®
DSP system) and a Wyatt/Optilab interferometric
refractometer.

6.0x10 7

3.0x10 7

20.0x10 6

15.0x10 6
1.0x10 7
2.0

2.3

2.6
Volume (ml)

2.9

3.2
Figure 4.

Figure 3.

Molecular weight distribution of the intact MUC2 mucins
The purified intact MUC2 mucins were dialysed against 4
M GuHCl and subsequently chromatographed at room
temperature on a Sephacryl S300 column (10 x 2 cm)
eluted with 4 M GuHCl at a flow rate of 0.5 ml/min. The
effluent was monitored by a multi-angle light scattering
detector (Dawn® DSP system) and molecular weight
distribution of intact MUC2 molecules was shown.

Discussion
It has been demonstrated previously that mucins
synthesised by the colonic cell line PC/AA are
predominantly products of the MUC2 gene (4,9,10,13).
In the present study we determined a polydisperse
distribution of these MUC2 gene products by exploiting
their large molecular mass with rate-zonal centrifugation
followed by laser-light scattering techniques. In our
previous paper, using isopicnic density-gradient
centrifugation we defined polydispersity and
heterogeneity of colonic MUC2 mucins on the basis of
376
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Molecular weight distribution of the reduced MUC2
subunits
The purified intact MUC2 mucins were reduced and
dialysed against 4 M GuHCl, and subsequently
chromatographed at room temperature on a Sephacryl
S300 column (10 x 2 cm) eluted with 4 M GuHCl at a flow
rate of 0.5 ml/min. The effluent was monitored by a multiangle light scattering detector (Dawn® DSP system) and
molecular weight distribution of reduced MUC2 subunits
was shown.

their buoyant densities (4). We characterised three MUC2
populations in different densities that were
unglycosylated, partially glycosylated and fully
glycosylated MUC2 species. However, in that
investigation the presence of three populations with
different buoyant densities shows that heterogeneity
could be superimposed on polydispersity. Thus, here we
worked on the purified MUC2 molecules in which we do
not expect to find unglycosylated and/or partially
glycosylated species (immature MUC2 molecules) but
fully glycosylated (mature molecules) MUC2 molecules.

N. AKSOY, J. K. SHEEHAN

Unfortunately, isopicnic density-gradient centrifugation
was not effective in demonstrating the polydispersity of
the purified mature MUC2 molecules, because all
polymeric forms of MUC2 were fully glycosylated and
detected almost at the same buoyant densities. We
therefore tried to show the polydispersity by using ratezonal centrifugation that separates particles according to
their sedimentation coefficiencies. By this method, we
detected that the purified intact MUC2 mucin
preparations contain at least three populations of
molecules that differ with respect to their sedimentation
coefficients. The LUM2-3 reactivity of these three
populations increased parallel to their sedimentation
rates. A similar distribution was observed with PAS
indicating the presence of the increasing density of
glycosylation on the MUC2 mucin polypeptide. This is in
agreement with Sheehan and Carlstedt, who described a
linear relationship between the sedimentation coefficient
and Mr for cervical mucins (3). The polydisperse
distribution of MUC2 mucins is very similar to those
previously described for cervical (3) and respiratory (14)
mucus glycoproteins with respect to both molecular size
and buoyant density. It is therefore possible to assume
that polydispersity is a characteristic feature of mucins.
The polydisperse structure of MUC2 mucins was also
supported by the measurement of Mr and RG with an inline Dawn® DSP laser photometer and a Wyatt/Optilab
903 interferometric refractometer (Optichem, Clywd,
UK). The refractive index measurement profile
demonstrated that the populations of MUC2 molecules
showed a continuous increase in molecular mass towards
the bottom fractions of the gradient. The intact MUC2
mucins isolated from a colonic cell layer extract were
polydisperse in size as seen by the measurement of RG.
This must arise from a variable number of subunits in the
intact oligomeric mucins. In common with the gelforming mucins isolated from respiratory (14) and
cervical tracts (15) that had oligomeric structure they can
be fragmented into their constituent subunits by
reduction of disulphide bonds.
Reduction of disulphide bonds cleaved the large
polydisperse molecules into smaller and more uniformly
sedimenting species on the rate-zonal guanidinium
gradient, and supported the finding that the mucins are

assembled from subunits joined end-to-end (3,4,9,13).
We previously demonstrated that MUC2 reduced mucin
subunits are heterogeneous in their charge distribution
and two major populations of molecules can be observed
(4). We have also noted differently glycosylated
populations of this mucin in the cell layer extract. The two
populations of MUC2 mucin subunits can be distinguished
on the basis of glycan-epitope specific monoclonal
antibodies and there is evidence that the lower charged
form has a higher mannose content (4). However,
carbohydrate compositional data indicates the two
populations may have similar glycan structures (data not
shown). The heterogeneity in charge density of the MUC2
mucin subunits is not accompanied by any significant
change in their molecular mass, approximately 16 x 106.
In light of this investigation it is possible to conclude
that the colonic MUC2 mucins have a common
macromolecular architecture with the other gel-forming
secretory mucus glycoproteins such as cervical,
respiratory and salivary mucins (15-16) and thus that all
secretory mucins are well described as linear polymeric
chains. It is also concluded that the application of ratezonal centrifugation and laser light-scattering techniques
could certainly become very useful for the investigation of
the structural features of macromolecules, which will give
us an opportunity to go one step further in early
diagnosis and following of the treatment and prognosis
for several serious diseases such as cancer, cystic fibrosis
and colitis ulcerosa at the molecular level.
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